Cargando…

Somatostatin receptor expression and clinical outcome of multilineage pituitary tumours expressing PIT1 and SF1

The application of transcription factor immunohistochemistry to pituitary neuroendocrine tumour (PitNET) assessment has allowed identification of tumours that do not conform to a single lineage. Multilineage pituitary transcription factor 1 (PIT1) and steroidogenic factor 1 (SF1) PitNETs are a rare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fookeerah, Prishila, Varikatt, Winny, Shingde, Meena, Dexter, Mark A J, McLean, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563595/ https://www.ncbi.nlm.nih.gov/pubmed/37851558 http://dx.doi.org/10.1530/EC-23-0328

Ejemplares similares

Aneurysmal subarachnoid haemorrhage in the pituitary fossa of a patient with acromegaly – a rare phenomenon
por: Fookeerah, Prishila, et al.
Publicado: (2023)

Ectopic insulin secretion by a large‐cell neuroendocrine carcinoma of the cervix
por: Wang, Mawson, et al.
Publicado: (2020)

A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' Disease
por: KIKUTA, Haruhiko, et al.
Publicado: (2023)

Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 – molecular pathways
por: Cakir, Mehtap, et al.
Publicado: (2010)

New onset headache caused by histiocytic sarcoma of the spinal cord and leptomeninges: a case report
por: Silsby, Matthew, et al.
Publicado: (2021)

Plurihormonal Pit-1 lineage adenoma presenting as meningitis with recurrence after somatostatin analogue
por: Olmedilla, Yoko, et al.
Publicado: (2019)

MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019)

Melatonin mediates monochromatic light-induced expression of somatostatin in the hypothalamus and pituitary of chicks
por: Qin, Xiaojing, et al.
Publicado: (2021)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

Pathogenesis of Anti–PIT-1 Antibody Syndrome: PIT-1 Presentation by HLA Class I on Anterior Pituitary Cells
por: Kanie, Keitaro, et al.
Publicado: (2019)

SAT-LB24 Association of Expression of Somatostatin Receptor 2 Subtype in Non-Pituitary Neuroendocrine Tumors With Response to Treatment With Somatostatin Analogues
por: Siddiqui, Abdullah, et al.
Publicado: (2020)

“An Unexpected Pit” - Ectopic Pituitary Adenoma
por: Aftab, Hassaan B, et al.
Publicado: (2021)

Pituitary Apoplexy in Patients with Pituitary Neuroendocrine Tumors (PitNET)
por: Gheorghe, Ana-Maria, et al.
Publicado: (2023)

THU095 Multilineage Plurihormonal (FSH LH TSH PRL ACTH) Pituitary Neuroendocrine Tumour: A Case Report
por: Mahfuza, Ummul K, et al.
Publicado: (2023)

Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Yu, Benxia, et al.
Publicado: (2017)

Retracted: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Song, Hao, et al.
Publicado: (2018)

MON-288 TSH Deficiency in Patients on Somatostatin Analog for TSH-PitNET
por: Illouz, Frederic, et al.
Publicado: (2020)

A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx
por: Peters, Jessica, et al.
Publicado: (2023)

Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2 – clinical implications
por: Cakir, Mehtap, et al.
Publicado: (2010)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Multilineage commitment of Sca-1(+) cells in reshaping vein grafts
por: Ni, Zhichao, et al.
Publicado: (2023)

Regulatory Mechanisms of Somatostatin Expression
por: Ampofo, Emmanuel, et al.
Publicado: (2020)

Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Somatostatin-Expressing Interneurons Form Axonal Projections to the Contralateral Hippocampus
por: Eyre, Mark D., et al.
Publicado: (2019)

ODP293 Aberant Expression of SF-1 Transcription Factor in ACTH-secreting Pituitary Tumors: Possible Association With Aggressive Disease Evolution
por: Nastase, Valeria, et al.
Publicado: (2022)

Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
por: Saksis, Rihards, et al.
Publicado: (2023)

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

A Case of TSH-Secreting Pituitary Adenoma With Unusual Positive Staining for SF1
por: Robinson, Kathleen, et al.
Publicado: (2021)

Improved multilineage human hematopoietic reconstitution and function in NSGS mice
por: Wunderlich, Mark, et al.
Publicado: (2018)

Neuroendocrine Adenoma of the Middle Ear: A Rare Histopathological Diagnosis
por: Hasan, Zubair, et al.
Publicado: (2016)

SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements
por: van der Meulen, Merel, et al.
Publicado: (2020)

Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation — High-Grade PitNET or PitNEC?
por: Saeger, Wolfgang, et al.
Publicado: (2021)

Somatostatin receptor 1–5; expression profiles during rat development
por: Ludvigsen, Eva, et al.
Publicado: (2015)

Expression of somatostatin and its receptor 1–5 in endometriotic tissues and cells
por: Zhao, Yanhua, et al.
Publicado: (2018)

Somatostatin receptor expression in parathyroid neoplasms
por: Storvall, Sara, et al.
Publicado: (2019)

How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
por: Trouillas, Jacqueline, et al.
Publicado: (2020)

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
por: Wang, Ji-wen, et al.
Publicado: (2014)

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement
por: Peverelli, Erika, et al.
Publicado: (2015)

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
por: Colao, Annamaria, et al.
Publicado: (2015)

XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells
por: Xing, Zhaoquan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4ro787vvvgn2oo48ddcla6bdhg